BCL2 and hepatocellular carcinoma: Our work demonstrated that lipase might be an ideal anticancer candidate, specific to cancer cells, for treating hepatocellular carcinoma (HepG-2) by its necrotic and apoptotic activities in addition to its effect in inducing downregulation (62%) of Bcl-2 gene.